Idg-sw3 Cells

The culture switch separates cell expansion from podocyte maturation. At 33°C with interferon-γ, the temperature-sensitive SV40 large T antigen supports proliferation, allowing researchers to increase cell numbers. Moving cultures to 37°C and removing interferon-γ shifts the cells toward differentiation, creating a controlled sequence that supports reproducible kidney model development.

Conditional immortalization provides access to proliferating cells without keeping them permanently in an immature state. IDG-SW3 cultures can first be expanded under defined conditions and then transitioned toward a more mature podocyte phenotype. This flexibility helps researchers examine both cell production and differentiated functions within the same experimental platform.

After the maturation shift, IDG-SW3 cells can support investigations of podocyte structure and filtration-barrier function. Researchers can also examine cellular injury and responses to candidate therapies. These outcomes connect cell state with kidney-relevant behavior, making the model useful for evaluating how engineered conditions or treatments affect glomerular epithelial performance.

A typical workflow begins by maintaining IDG-SW3 cells at 33°C in the presence of interferon-γ to obtain a proliferating culture. Researchers then shift the culture to 37°C and remove interferon-γ to promote differentiation and maturation. The resulting cells can be incorporated into or evaluated within engineered glomerular filtration systems.

In bioengineering, differentiated IDG-SW3 cells provide a podocyte component for in vitro glomerular filtration models. Their controllable growth and maturation can help researchers build systems that represent aspects of the kidney filtration barrier. Such platforms support testing of barrier function, cellular injury, and candidate therapeutic responses under controlled laboratory conditions.

The model can be used to investigate how podocyte structure relates to filtration-barrier behavior and how cellular injury changes that function. It also enables assessment of candidate therapies in a kidney-relevant setting. These applications support efforts to create more physiologically relevant engineered renal tissues rather than relying only on undifferentiated cell cultures.